Literature DB >> 10744041

Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats.

T Tanaka1, K Kawabata, H Kohno, S Honjo, M Murakami, T Ota, H Tsuda.   

Abstract

The modifying effects of dietary feeding of bovine lactoferrin (bLF) on tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide (4-NQO) were investigated in male F344 rats. The activities of phase II detoxifying enzymes, glutathione S-transferase (GST) and quinone reductase (QR), polyamine content and ornithine decarboxylase (ODC) activity in the tongue were also examined for mechanistic analysis of possible modifying effects of bLF on carcinogenesis. At 7 weeks of age, all animals except those treated with bLF alone and untreated rats were given 20 ppm 4-NQO in drinking water for 8 weeks to induce tongue neoplasms. Starting 7 days before 4-NQO exposure, experimental groups were fed experimental diets containing bLF (0.2% and 2%) for 10 weeks ("initiation feeding"). Starting 1 week after the cessation of exposure to 4-NQO, the other experimental groups given 4-NQO and a basal diet were fed the experimental diets for 22 weeks ("postinitiation feeding"). At week 32, the incidence and multiplicity of tongue neoplasms in the "initiation feeding" groups of 0.2% and 2% bLF and the "post-initiation feeding" group of 0.2% bLF were lower than those of the 4-NQO alone group, but without statistical significance. However, "post-initiation feeding" of 2% bLF caused a significant reduction in the incidence (20% vs. 55%, P=0.02418) and multiplicity (0.25+/-0.54 vs. 0.70+/-0.71, P<0.05) of tongue squamous cell carcinoma (by 64%, P=0.02418). bLF treatment elevated liver and tongue GST activities and liver QR activity. The "post-initiation feeding" with 2% bLF significantly decreased QR activity, proliferating cell nulcear antigen-positive index and ODC activity in the tongue. In addition, feeding with bLF decreased tongue polyamine content. These results suggest that bLF, when given at the 2% dose level during the post-initiation phase, exerts chemopreventive action against tongue tumorigenesis through modification of cell proliferation activity and/or the activities of detoxifying enzymes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744041      PMCID: PMC5926223          DOI: 10.1111/j.1349-7006.2000.tb00856.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  48 in total

Review 1.  Possible mechanisms by which alcohol may influence the development of oral cancer--a review.

Authors:  A J Wight; G R Ogden
Journal:  Oral Oncol       Date:  1998-11       Impact factor: 5.337

2.  Risk of tongue cancer associated with tobacco smoking and alcohol consumption: a case-control study.

Authors:  T Zheng; T Holford; Y Chen; P Jiang; B Zhang; P Boyle
Journal:  Oral Oncol       Date:  1997-03       Impact factor: 5.337

3.  Definition of leukoplakia and related lesions: an aid to studies on oral precancer.

Authors:  I R Kramer; R B Lucas; J J Pindborg; L H Sobin
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1978-10

Review 4.  Cell proliferation in carcinogenesis.

Authors:  S M Cohen; L B Ellwein
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

5.  1,4-phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis.

Authors:  T Tanaka; H Makita; K Kawabata; H Mori; K El-Bayoumy
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

Review 6.  Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview.

Authors:  P A Swango
Journal:  J Public Health Dent       Date:  1996       Impact factor: 1.821

7.  Chemoprevention of oral carcinogenesis by DL-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor: dose-dependent reduction in 4-nitroquinoline 1-oxide-induced tongue neoplasms in rats.

Authors:  T Tanaka; T Kojima; A Hara; H Sawada; H Mori
Journal:  Cancer Res       Date:  1993-02-15       Impact factor: 12.701

8.  Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem.

Authors:  G J Macfarlane; P Boyle; T V Evstifeeva; C Robertson; C Scully
Journal:  Cancer Causes Control       Date:  1994-05       Impact factor: 2.506

Review 9.  Epidemiology of mouth cancer in 1989: a review.

Authors:  P Boyle; G J Macfarlane; P Maisonneuve; T Zheng; C Scully; B Tedesco
Journal:  J R Soc Med       Date:  1990-11       Impact factor: 18.000

10.  Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice.

Authors:  Y C Yoo; S Watanabe; R Watanabe; K Hata; K Shimazaki; I Azuma
Journal:  Jpn J Cancer Res       Date:  1997-02
View more
  10 in total

1.  Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo.

Authors:  Jeffrey S Wolf; Guoyan Li; Atul Varadhachary; Karel Petrak; Mark Schneyer; Daqing Li; Julina Ongkasuwan; Xiaoyu Zhang; Rodney J Taylor; Scott E Strome; Bert W O'Malley
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

2.  Lactoferrin reduces methotrexate-induced small intestinal damage, possibly through inhibition of GLP-2-mediated epithelial cell proliferation.

Authors:  Belinda van't Land; Noortje M A van Beek; Jeroen J M van den Berg; Laura M'Rabet
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

3.  Oral carcinogenesis and oral cancer chemoprevention: a review.

Authors:  Takuji Tanaka; Mayu Tanaka; Takahiro Tanaka
Journal:  Patholog Res Int       Date:  2011-05-22

4.  Understanding carcinogenesis for fighting oral cancer.

Authors:  Takuji Tanaka; Rikako Ishigamori
Journal:  J Oncol       Date:  2011-05-12       Impact factor: 4.375

5.  Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin.

Authors:  W P Wang; M Iigo; J Sato; K Sekine; I Adachi; H Tsuda
Journal:  Jpn J Cancer Res       Date:  2000-10

6.  Different iron-handling in inflamed small and large cholangiocytes and in small and large-duct type intrahepatic cholangiocarcinoma.

Authors:  Romina Mancinelli; Antimo Cutone; Luigi Rosa; Maria Stefania Lepanto; Paolo Onori; Luigi Pannarale; Antonio Franchitto; Eugenio Gaudio; Piera Valenti
Journal:  Eur J Histochem       Date:  2020-10-19       Impact factor: 3.188

7.  Isolation and characterization of bioactive lactoferrin from camel milk by novel pH-dependent method for large scale production.

Authors:  Neelam Mahala; Aastha Mittal; Manohar Lal; Uma S Dubey
Journal:  Biotechnol Rep (Amst)       Date:  2022-09-21

8.  Inhibitory effects of human lactoferrin on U14 cervical carcinoma through upregulation of the immune response.

Authors:  Huaiping Shi; Wenye Li
Journal:  Oncol Lett       Date:  2013-12-27       Impact factor: 2.967

9.  Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats.

Authors:  Ken-ichi Fujita; Takamasa Ohnishi; Kazunori Sekine; Masaaki Iigo; Hiroyuki Tsuda
Journal:  Jpn J Cancer Res       Date:  2002-06

Review 10.  Lactoferrin's Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action.

Authors:  Antimo Cutone; Luigi Rosa; Giusi Ianiro; Maria Stefania Lepanto; Maria Carmela Bonaccorsi di Patti; Piera Valenti; Giovanni Musci
Journal:  Biomolecules       Date:  2020-03-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.